Gapping up
In reaction to strong earnings/guidance: THO +8.6%, TIF +5.1%, BERY +4.6%, UNH +3.2%, ZTO +2.6%, BNS +1.3%
M&A news: RMAX +1.4% (light volume; acquires the Master Franchise for the Georgia, Kentucky/Tennessee, and Southern Ohio Regions; terms not disclosed)
Select financial related names showing strength: DB +2.8%, PUK +1.6%, ING +1.3%, CS +0.8%, LYG +0.7%
Other news:
In reaction to strong earnings/guidance: THO +8.6%, TIF +5.1%, BERY +4.6%, UNH +3.2%, ZTO +2.6%, BNS +1.3%
M&A news: RMAX +1.4% (light volume; acquires the Master Franchise for the Georgia, Kentucky/Tennessee, and Southern Ohio Regions; terms not disclosed)
Select financial related names showing strength: DB +2.8%, PUK +1.6%, ING +1.3%, CS +0.8%, LYG +0.7%
Other news:
- CYTR +42.9% (announces 'positive' updated results from its pivotal Phase 3 clinical trial evaluating aldoxorubicin)
- CBMX +29.6% (announces that its pre-implantation genetic screening by next generation sequencing test has received conditional approval from the New York State Department of Health)
- VBLT +22% (announces top-line results from its exploratory Phase 2 study of VB-111g)
- MNTA +12.2% (Phase 3 clinical study of M923 in patients with moderate-to-severe chronic plaque psoriasis, met its primary endpoint)
- OCUL +11.8% (to present at Piper Jaffray Healthcare Conference tomorrow)
- KNDI +6.9% (received a second subsidy payment of RMB 100 million)
- P +5% (Pete Najarian in the 'Final Trade' segment of CNBC's Fast Money program pointed out 'huge call buying' that occured late in yesterday's session)
- TIVO +3.9% (TiVo and Netflix enter into product and intellectual property agreements)
- PZRX +3.5% (following 150% move higher on Monday)
- ARIA +3.3% (FDA has granted Iclusig full approval)
- SAN +1.6% (receives ECB decision for 2017 capital requirements; must maintain CET1 ratio of 7.75%)
- BT +1.1% (appoints Chairman of Openreach; provides response to Ofcom statement)
Analyst comments:
- BCS +2.8% (initiated with an Outperform at Credit Suisse)
- ONVO +2.2% (initiated with a Buy at Evercore ISI)
- FIT +1.5% (Longbow out positive following FIT's strong showing this holiday weekend)
- PFE +0.9% (upgraded to Overweight from Equal Weight at Barclays)